Leukemia & Lymphoma, 2026
Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridine

Mina A., Calvo K., McKinnon K. et al.

International Journal of Molecular Sciences, 2026
UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis

Kang S., Kim S., Ban J. et al.

International Journal of Molecular Sciences, 2026
Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes

Zieleniewska N., Jamiołkowski J., Malarstig A. et al.

Clinical Cardiology, 2026
Plasma EDA2R and Risk of Cardiovascular Diseases and All‐Cause Mortality: Analysis of the UK Biobank Cohort

Ruan Z., Tu J., Xu H. et al.

Nature Medicine, 2026
AI framework for multidisease detection via retinal imaging

Zhang X., Li Q., Liang Y. et al.

Pediatric Hematology and Oncology, 2026
The influence of elevated body mass index on protein expression in pediatric b-cell acute lymphoblastic leukemia

Werk R., Chacón J., Turcotte L. et al.

Proceedings of the National Academy of Sciences, 2026
Unveiling the glymphatic system’s role in brain aging: A comprehensive biomarker and modifiable intervention target

Fang Y., Luo W., Huang H. et al.

npj Dementia, 2026
Targeted profiling of the serum proteome associates increased FGF-23 levels with postoperative delirium in cardiac surgical patients

Simon C., Kelly Graves O., Williams V. et al.

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2026
Effects of a Short-Term Multicomponent Functional Exercise Program on the Serum Proteome: An Exploratory Study in Hospitalized Older Adults

Izco-Cubero M., Lachén-Montes M., Chenhuichen C. et al.

Journal of Allergy and Clinical Immunology, 2026
Comprehensive molecular profiling of Hispanic, Black, Asian, and White atopic dermatitis via tape strip RNAseq and serum proteomics

Liu D., Del Duca E., Brunner P. et al.

npj Parkinson's Disease, 2026
Plasma proteomics for Parkinson’s disease classification: cross-cohort benchmarking of proteomic, transcriptomic, and multimodal models

Minster N., Jafri S.

VIEW, 2026
Proteomic and metabolic signatures of female reproductive factors and risk of age‐related ocular diseases: A large prospective cohort study

Jian L., Huang Z., Zhang K. et al.

Nature Immunology, 2026
A spatially coordinated keratinocyte–fibroblast circuit recruits MMP9+ myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity

Wang Y., Afshari K., Haddadi N. et al.

Frontiers in Immunology, 2026
Longitudinal plasma proteomics identifies diagnostic and response-associated inflammatory and immune biomarkers in psoriasis following secukinumab therapy

Zhang H., Yang R., Ma Y. et al.

Frontiers in Immunology, 2026
Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar

Bentebbal S., Zaqout A., Meqbel B. et al.

Alzheimer's Research & Therapy, 2026
Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ+ and Aβ- dementia with Lewy bodies patients

Oosthoek M., In ’t Veld S., Vermunt L. et al.

Neurology Neuroimmunology & Neuroinflammation, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis

Oechtering J., Schaedelin S., Maleska Maceski A. et al.

JCI Insight, 2026
Pan-cancer polygenic risk score associates with cancer susceptibility following kidney transplantation

Ritari J., Hyvärinen K., Jahnukainen K. et al.

Journal of Inherited Metabolic Disease, 2026
Multimodal Noninvasive Biomarker Characterization of Structural and Functional Alterations in ADSS1 ‐Deficient Myopathy

Yekedüz M., van Gool R., van der Heijden H. et al.

American Journal of Preventive Cardiology, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort

Wang N., Bhatt D., Xhaard C. et al.